Pfizer and BioNTech have applied for approval for their COVID vaccine in Europe. The application is for conditional marketing authorization. BioNTech said if the European Medicines...
The Swiss franc was soft for the most part today, though it managed to log small gains versus the Australian dollar and the Japanese yen. Better-than-expected domestic macroeconomic data was unable to bolster the Swissie....
Shares of Novavax sank more than 9% in Monday’s pre-market session as the drugmaker further delayed the start of the US late-stage trial of its COVID-19...
After what can only be described as a tumultuous year, with 2021 at the gate, both Wall Street and Main Street are exuding a sense of...
Moderna has inked a deal to supply European Union countries with up to 160 million doses of its COVID-19 vaccine candidate. The supply deal comes after...
U.S. officials plan to release 6.4 million Covid-19 vaccine doses nationwide in an initial distribution after the first one is cleared by regulators for emergency use.
The United Nations recently asked a group of experts across the world to recommend ways to persuade people to take a COVID-19 vaccine. Here is a...
The United Nations recently asked a group of experts across the world to recommend ways to persuade people to take a COVID-19 vaccine. Here is a...
Generally, companies in the healthcare sector show resilience amid challenging macro conditions. However, certain healthcare stocks have been under pressure during the pandemic due to supply...
Unfortunately, Covid-19 is still on the rampage across the globe. However, the good news is that the newest data coming from late stage studies indicates a...
The U.S. government will start distributing Regeneron Pharmaceuticals Inc.’s newly authorized Covid-19 antibody combination on Nov. 24, beginning with more than 30,000 treatment courses, a health...
CNBC Transcript: Regeneron Chairman and CEO Dr. Leonard Schleifer speaks With CNBC’s Meg Tirrell on “Squawk Box” today on the distribution of Covid-19 antibody cocktail. Q3...
CNBC Exclusive: CNBC Transcript: Oncolmmune Founder and CEO Dr. Yang Liu speaks with CNBC’s “Squawk Box” today, discussing Oncolmmune being acquired by Merck. Q3 2020 hedge...
AstraZeneca said that its coronavirus vaccine candidate, which it is developing together with Oxford University, has shown an average efficiency of 70% and met the primary...
U.S. healthcare workers and others recommended for the nation’s first Covid-19 inoculations could start getting shots within a day or two of regulatory consent in December,...
The U.S. Food and Drug Administration issued emergency use authorization for Regeneron Pharmaceuticals Inc.’s Covid-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump...
Regeneron announced that its REGN-COV2 investigational antibody cocktail therapy for the treatment of COVID-19, has been granted Emergency Use Authorization (EUA) by the US Food and...
Pfizer files Covid-19 vaccine application to U.S. FDA
Pfizer is first to apply for U.S. emergency use for Covid-19 vaccine
COVID-19 vaccines were developed in record time – but are these game-changers safe?
Pfizer Expected to File FDA EUA Application for COVID-19 Vaccine Today
Lilly’s baricitinib granted US emergency use in COVID-19
Eli Lilly Arthritis Drug Gets Emergency Green-Light As COVID-19 Treatment
FDA Grants EUA to Combination of Olumiant and Remdesivir in Hospitalized Covid-19 Patients
AstraZeneca and Oxford’s Covid-19 Vaccine Shows Promise in Elderly Adults
Pfizer, LianBio Partner To Develop Therapeutics In Greater China
Encouraging data from AZ/Oxford coronavirus shot
BioNTech says vaccine approval possible in mid-December under ideal conditions
Don’t Discount This Coronavirus Stock Just Yet, Says Analyst
FDA approves first Covid-19 test kit for home use